Stock Price
94.15
Daily Change
0.32 0.34%
Monthly
9.67%
Yearly
42.85%
Q4 Forecast
92.15

EPS Reference Time Actual Consensus Previous
2026-11-03 FY2026Q3 PM 1.13 1.05
2026-08-04 FY2026Q2 PM 0.82 1.09 1.15
2026-05-05 FY2026Q1 PM 1.25 1.08 1.20
2026-02-11 FY2025Q4 PM 0.80 0.83 0.97
2025-11-04 FY2025Q3 PM 1.05 1.02 1.04



Peers Price Chg Day Year Date
Albemarle 93.67 1.13 1.22% -11.33% Oct/23
Air Products & Chemicals 307.15 -1.07 -0.35% 20.49% Oct/23
Ashland 72.99 -0.58 -0.79% 44.48% Oct/23
Axalta Coating Systems 34.14 -0.91 -2.60% 17.56% Oct/23
Conagra Foods 14.86 -0.21 -1.39% -18.75% Oct/23
Celanese 47.71 0.49 1.04% 13.03% Oct/23
CF Industries 120.68 2.12 1.79% 39.56% Oct/23
Church & Dwight 105.19 -3.67 -3.37% 22.47% Oct/23
Colgate-Palmolive 94.04 -3.35 -3.44% 20.56% Oct/23
Clorox 86.40 -2.26 -2.55% -25.42% Oct/23

Indexes Price Day Year Date
US Index 500 7655 -39.75 -0.52% 12.71% Oct/25

International Flavors Fragrances traded at $94.15 this Friday October 23rd, increasing $0.32 or 0.34 percent since the previous trading session. Looking back, over the last four weeks, International Flavors Fragrances gained 9.67 percent. Over the last 12 months, its price rose by 42.85 percent. Looking ahead, we forecast International Flavors Fragrances to be priced at 92.15 by the end of this quarter and at 86.42 in one year, according to Trading Economics global macro models projections and analysts expectations.

International Flavors & Fragrances Inc. offers sensory, food and beverage, pharmaceutical, health and wellness, home and personal care solutions and ingredients. It operates through segments such as Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment consists portfolio of natural-based ingredients to improve nutritional value, texture and functionality in a range of beverage, dairy, bakery, confectionery and culinary applications. The Scent segment consists of its legacy Scent segment as well as its Flavor Ingredients business. The Health & Biosciences segment includes a biotechnology-driven probiotics portfolio, that produces cultures for use in fermented foods such as yogurt, cheese and fermented beverages. The Pharma Solutions segment consists of cellulosics and alginates-based pharma excipients.